News Release Detail
Mylan Laboratories Names Patrick Fitzgerald Vice President, Public Relations
Fitzgerald has extensive experience leading strategic communications efforts for public companies as well as clients at international PR firms. He most recently served as Director of Public Relations for General Nutrition Centers (GNC), a leading international specialty retailer of nutritional supplements. Prior to his tenure at GNC Fitzgerald held senior positions with Ketchum Public Relations and Edelman Public Relations. He also spent 6 years with Midway Games Inc., a New York Stock Exchange listed interactive entertainment publisher headquartered in Chicago. While at Midway Fitzgerald served as Director of Corporate Communications and Investor Relations and helped guide the company through a series of events, including an initial public offering and the acquisition of Atari Games.
Robert J. Coury, Mylan's Vice Chairman and Chief Executive Officer stated, "We are very fortunate to have Patrick added to our team to lead our strategic communications activities with our customers, employees and shareholders."
Patrick Fitzgerald commented, "I have done extensive due diligence on Mylan prior to joining the team and I am extremely excited about coming on board. I believe Mylan is well positioned for further growth and I look forward to contributing to the company's continued success."
Mylan Laboratories Inc. is a leading pharmaceutical company with four subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Mylan Bertek Pharmaceuticals Inc., that develop, license, manufacture, market and distribute an extensive line of generic and proprietary products.
For more information about Mylan, visit www.mylan.com.
This press release includes statements that constitute "forward-looking statements", including with regard to the anticipated growth and future success of the Company. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward- looking statements. Factors that could cause or contribute to such differences include, but are not limited to: the effects of vigorous competition on the commercial acceptance of the Company's products and their pricing; the Company's exposure to lawsuits, regulatory and legislative changes and other contingencies associated with its business outside the control of management; and the other risks detailed in the Company's periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release.
SOURCE Mylan Laboratories Inc.
05/11/2005
CONTACT: Patrick Fitzgerald (media), or Kris King (investors), both of
Mylan Laboratories Inc., +1-724-514-1800
Web site: http://www.mylan.com